2025 Post AEP Insight Series: Report 1 📊

Medicare Advantage 2025: A Market in Transition and Strategic Imperatives for Bid Season 2026

Prepping Your 2026 Medicare Advantage Bid? Don't Miss These 2025 Trends!

April 16, 2024       Market Research

Table of Contents

Summary

  • National Enrollment Growth Slowing: Enrollment grew by only 4.57% YoY, slowed in recent years, signaling market saturation.
  • Plan Landscape Shifting: For the first time in years, total plan count declined (-1.72% YoY), and Service Area Reductions (SAR) rose, highlighting plan consolidation.
  • C-SNP Plans Surge: C-SNPs saw 21.4% growth in plan count and a massive 67.7% enrollment increase, making them the standout product type this AEP.
  • $0 Premium Plans & Part B Giveback Grow: $0 premium plans now account for 76.5% of enrollment, and Part B Giveback enrollment nearly tripled YoY, growing 248% to reach 8.68 million in 2025.
  • State-Level Concentration & Swings: The top 5 states, Florida, California, Texas, Pennsylvania, and New York account for 37% of all MA enrollees, while some states like New York and Vermont saw net enrollment losses.Benefit Trends Shift: Essential benefits (Emergency, Dental Preventive, Physical Exams) drove large enrollment gains—even as overall availability declined.

Introduction

As the Medicare Advantage (MA) market continues to evolve, the 2026 bid season offers insurers various opportunities and challenges. Although enrollment growth persists, it has slowed, with total enrollment reaching 33 million beneficiaries. For the first time over the years, the total number of MA plans declined in 2025, indicating a potential slowdown in market expansion. This shift suggests intensified competition, financial pressures, and evolving regulatory dynamics that could affect plan offerings and pricing strategies. This article explores the key trends influencing the upcoming bid season, with all analyses based on February 2025 enrollment data. It examines national and state-level developments, shifts in enrollment patterns, and trends across Special Needs Plans (SNPs) and plan types. Cost metrics such as premiums, drug deductibles, and Maximum Out-of-Pocket (MOOP) are evaluated alongside a benefits overview, offering insurers and stakeholders critical insights to navigate the evolving Medicare landscape. Utilizing data from the Centers for Medicare & Medicaid Services (CMS), we aim to uncover the factors driving these changes and provide insights for making strategic decisions.

National Overview

Key Trends:

  • Enrollment Growth Slowing: While MA enrollment grew to 7 million in 2025 (a 4.57% YoY increase), the net gain (428K) is much lower compared to 723K in 2024 and 1.2M in 2022—signaling a maturing, saturated market.
  • Plan Count Declines: The total number of plans dropped 1.72% YoY to 5,705—the first such decline in years, reversing prior growth.
  • Service Area Adjustments: Plans with Service Area Reductions (SAR) increased sharply to 5% of the total, while those with expansions (SAE) declined notably.

In 2025, the Medicare plans experienced a 1.72% year-over-year (YoY) decline, reducing the total number of plans to 5,705. This marks the first decline in recent years, reversing the steady but slowing growth from 2020 to 2024.

Despite the decline in the total number of plans in 2025, enrollment has continued to grow at 4.57% YoY, reaching 28.7 million beneficiaries. However, the net enrollment increase has slowed over the years, with only 428,856 new enrollees in 2025 compared to 723,512 in 2024 and over 1.2 million in 2022. This suggests gradual market saturation, requiring insurers to rethink their value propositions to attract new enrollees.

Examining plan distribution, New Plans and Initial Contracts saw an increase, collectively making up 14.20% of total plans. In contrast, Renewal Plans (60.09%), Consolidated Renewal Plans (5.03%), and Renewal Plans with Service Area Expansion (SAE) (9.18%) all declined compared to 2024. Notably, Renewal Plans with Service Area Reduction (SAR) experienced a sharp increase, reaching 11.50% of total plans, signaling shifts in market dynamics.

From an enrollment perspective, New Plans has gained 1.36 million total beneficiaries as of February 2025. However, this reflects a   decline of 129,125 enrollees compared to the total enrollment in New Plans in December 2024. While Initial Contract Plans rebounded with 43,656 additional net enrollments after a decline in 2024. On the other hand, Renewal Plans saw a sharp decline, losing 991,390 net enrollments, while Consolidated Renewal Plans dropped by 79,061 net enrollments. The most significant reduction was observed in Renewal Plans with SAE, which lost 1.43 million net , reflecting a more cautious approach to expansion. In contrast, Renewal Plans with SAR grew significantly by 3.01 million enrollees currently, suggesting a strategic contraction in service areas to focus on high-performing markets.

Individual Plans

UnitedHealth Group continues to dominate the Medicare Advantage (MA) market in 2025, adding 492,630 net enrollments despite evolving industry dynamics. While some payors are expanding rapidly, others are experiencing slower growth or even declines, highlighting shifting competitive strategies. Florida and California maintained their positions as the top states for MA enrollment, reflecting their large senior populations. However, smaller states like Maryland and Missouri are emerging as key growth markets, posting higher YoY enrollment increases.

Group Plans

Group plans saw a sharp slowdown in growth in 2025, adding just 20,984 net enrollments, compared to 266,655 in 2024. Although total enrollment reached 5.7 million, the YoY growth rate fell to just 0.54%, marking the lowest level in recent years. This deceleration suggests that employer-sponsored MA plans may be nearing saturation, prompting payors to explore new strategies for sustaining growth.

MA Only/MAPD Overview

Key Plan & Product Trends

  • MAPD vs. MA Only: MA Only plans grew 4% YoY, rebounding from 2024. MAPD plans grew just 4.5%, continuing a downward trend.

MAPD plans declined by 106 plans, bringing the total to 5,215 in 2025. In contrast, MA Only plans that had decreased in 2024 rebounded in 2025 with an increase of 6 plans, reaching a total of 490.

Out of all plans, New Plans and Initial Contracts together represent 10.2% in MA Only and 14.6% in MAPD. The highest plan share is observed in Renewal Plans, comprising around 60% in both MA Only and MAPD plans.

MA Only enrollment growth is regaining momentum, rising by 7.4% YoY, reaching 875,201 enrollees in 2025 after slowing down to 6.3% in 2024. Meanwhile, MAPD enrollment growth has steadily declined from 9.4% in 2022 to 4.5% in 2025. Despite the growth in MA Only plans, MAPD remains the clear leader, accounting for over 97% (27.8 million) of total enrollments.

In 2025, MA Only and MAPD plans experienced contrasting net enrollment shifts. For MA Only plans, Consolidated Renewal Plans saw a moderate increase of 4,220 enrollees, while Initial Contracts added 1,126 members. However, New Plans lost 7,608 enrollees, and Renewal Plans with SAE saw a sharp decline of 106,357 members, indicating challenges in retaining beneficiaries. In contrast, Renewal Plans with SAR drove MA Only growth by reaching 170,926 enrollees. MAPD plans faced more significant fluctuations, with Consolidated Renewal Plans declining by 83,281 and New Plans losing 121,517 members. Traditional Renewal Plans dropped by 964,197, and Renewal Plans with SAE saw a significant loss of 1.32 million members, reflecting a shift in beneficiary preferences. Despite these losses, Renewal Plans with SAR offset the declines, adding 2.84M enrollees under this section.

State Overview

Key State-Level Insights

  • 5 Largest States = 37% of All MA Enrollees: California, Florida, Texas, New York, and Pennsylvania lead in both plan count and enrollment.
  • Fastest-Growing States: Wyoming (19.7%), Maryland (12.3%), ND, SD, WV showed double-digit or near-double-digit YoY growth.
  • Negative Enrollment States: New York (-49K), Vermont, New Mexico, and a few others saw net declines.

Over the past five years, Florida (592), California (421), Texas (385), Pennsylvania (316), and New York (236) have consistently ranked as the top five states for the number of MA plans. These states represent 37% of total beneficiaries, showcasing their strong market presence. California leads with 2.82 million enrollees, followed closely by Florida with 2.69 million, Texas with 2.12 million, New York with 1.68 million, and Pennsylvania with 1.35 million. This concentration emphasizes their continued dominance in MA enrollment, influencing the overall market dynamics.

Despite having the lowest enrollment at 20K, Wyoming leads with the highest YoY enrollment growth of 19.70% from 2024 to 2025, followed by Maryland (12.31%), reflecting substantial expansion in these states. Other states showing notable growth include North Dakota (9.46%), South Dakota (9.09%), and West Virginia (7.52%), signaling increasing MA adoption. Meanwhile, Delaware, Utah, Michigan, and Idaho demonstrate steady yet consistent enrollment growth of ~7% YoY, contributing to the overall expansion of the MA market.

Vermont is the only state experiencing negative growth, with a -7.4% YoY decline. Meanwhile, New York and New Mexico show relatively low growth rates compared to other states (<2% YoY), indicating slower MA expansion in these regions.

In 2024, all states experienced positive net enrollment, indicating an upward trend in MA participation. However, in 2025, while most states continued to grow, Pennsylvania led with the highest net gain of 32,806 new enrollees, closely followed by Michigan, which added 32,062 enrollees in February 2025. Conversely, New York saw the most significant decline, losing 49,113 enrollees. Other states with negative net enrollment included Vermont (-4,125), New Mexico (-3,306), Washington (-1,975), New Hampshire (-720), and Kansas (-422). Despite these declines, the overall market remains strong, with most states continuing to expand, with Florida, Texas, and Ohio each adding 30K+ enrollees.

SNP Overview

Key Plan & Product Trends

  • C-SNPs Surge: C-SNP plans grew 4% YoY in count and 67.7% in enrollment, becoming a key growth area.
  • D-SNPs Plateau: While still dominant, D-SNP growth slowed to 8% YoY.
  • I-SNPs & Non-SNPs Decline: Both continued to lose plans and enrollment.

The total number of SNP plans reached 1,501, a modest 9% increase from 2024. This growth was driven primarily by Chronic or Disabling Condition SNPs (C-SNPs), which saw the largest gain, expanding by 21.4% YoY from 322 plans in 2024 to 391 in 2025. Dual-Eligible SNPs (D-SNPs) also grew steadily, increasing from 875 to 945 plans, reinforcing their dominance with a 63% share of the total SNP market. Conversely, Institutional SNPs (I-SNPs) continued their downward trend, falling from 175 to 165 plans—a 5.7% decrease. Meanwhile, the Non-Special Needs Plans (Non-SNPs) experienced a rare decline, shrinking from 4,433 plans in 2024 to 4,204 in 2025.

Enrollment in SNPs continued to climb, with significant differences in growth across SNP types. C-SNPs experienced an exceptional surge, reaching 1.09 million enrollees, a 67.7% YoY increase, and contributing a net gain of 223,124 members compared to 2024. In contrast, D-SNPs, while still the largest segment with 6.02 million enrollees, saw only 3.8% growth over the previous year, a sharp deceleration from past trends, adding just 46,409 net new members. I-SNPs posted a modest total enrollment of 118,196 but experienced a net loss of nearly 4,838 enrollments and continued the downward trajectory in growth rate since 2023.

Meanwhile, Non-SNP enrollment also grew, albeit at a slower pace. Enrollment rose to 21.46 million in 2025, with a net gain of 164,161 members, translating to a 2.8% YoY growth rate—the lowest in the last four years. This slowdown suggests a shift in focus toward specialized and targeted care models like SNPs, especially C-SNPs, which are increasingly seen as a strategic growth area by health plans.

Plan Type Overview

The national decline in total plan count in 2025 broadly impacted all plan types. Local HMO and PPO plans, the two dominant plan types, saw notable declines in 2025, with Local HMO dropping 45 plans to 3,541 (62% of all plans), marking its second consecutive year of decline, while Local PPO saw its first reduction, losing 35 plans and totaling 2,010 (35% of all plans). Meanwhile, Cost, MMP, MSA, PFFS, and Regional PPO plans continued their gradual decline over the years, reflecting ongoing market adjustments.

Despite these plan reductions, Local HMOs remain the leader in enrollment, with 18.29 million beneficiaries, followed by Local PPOs with 9.76 million enrollees. Both plan types experienced net enrollment growth in 2025; however, Local HMO rebounded with 538,553 net enrollees i.e., 3% of total HMO enrollments after years of slowing growth, whereas Local PPO’s growth rate has progressively declined, rising by just 0.02% (1,725 net enrollees) in 2025, signaling a significant loss of momentum.

Beyond these leading plan types, other plan categories continued to see net enrollment declines in 2025. Cost plans dropped 5,518 enrollees, falling to 157,440, while MMP plans continued their downward trend, losing 6,222 enrollees due to state-level Medicaid shifts. MSA plans remained stagnant at just 768 enrollments, highlighting persistently low adoption. Regional PPO plans faced the steepest decline, losing 106,945 enrollees, plummeting from 986,951 in 2021 to just 216,079 in 2025, as enrollees gravitated toward Local PPOs and HMOs. PFFS plans were the exception, rebounding with a gain of 7,361 net enrollments, reflecting renewed interest in flexible provider access.

Premium Overview

Cost Structure & Benefit Trends

  • $0 Premium Plans Dominate: Now 5% of total enrollment, with 21.9M members.
  • Part B Giveback Explodes: Enrollment jumped 248% YoY to 8.68M across 1,748 plans.
  • High Deductible Drug Plans Rise: Plans with >$100 drug deductible increased 50% YoY; enrollment rose 84% YoY.
  • MOOP >$6,000 Plans Up: These now dominate, with 07M enrollees (+21.3% YoY).

Lower premium segments dominated the MA product strategy in 2025 as carriers continued shifting focus toward affordability. $0 premium plans reached a high of 3,878, up slightly from 3,849 in 2024, cementing their position as the dominant offering. The >$0 to <=$25 premium segment also rebounded strongly, with the plan count rising from 400 to 526, following a sharp reduction the year before. However, mid-tier premium plans (>$25 to <=$50) continued to shrink in availability, dropping from 936 to 683 plans, while plans in the >$50 to <=$200 premium buckets also declined modestly. The higher-premium segments remained limited, with just 57 plans in the >$200 to <=$300 range and only four plans charging over $300 premium.

These shifts in plan offerings were mirrored in enrollment patterns. $0 premium plans now account for 21.94 million enrollees, representing 76.5% of total MA enrollment. Although the YoY growth rate slowed to 8.2%, this segment continues to attract the bulk of beneficiaries. The >$0 to <=$25 premium segment bounced back with a 40.5% YoY increase in enrollment, reaching nearly 1.92 million, signaling renewed member interest in low-cost, flexible plan designs. Meanwhile, the >$25 to <=$50 premium category saw a sharp 26.5% YoY decline in enrollment, falling to 2.71 million, while higher-premium tiers continued their downward trajectory. Enrollees in the >$100 to <=$200 range declined to 555,251, and those in the >$200 to <=$300 bracket dropped to 96,387. Only the over $300 segment saw marginal growth, ending with just over 5,039 enrollees.

Across states, the $0 premium segment holds the largest share of enrollment, with North Dakota as the only exception, where the >$50 to ≤$100 premium segment leads. Florida tops the nation in $0 premium enrollment with 2.30 million beneficiaries, accounting for 85% of MA membership. UnitedHealth Group, Inc. leads the lower premium markets, especially the $0 premium tier, with over 5.78 million enrollees. CVS Health Corporation also maintains a strong foothold in this segment, enrolling 2.27 million beneficiaries, representing 83.99% of its total MA membership. Meanwhile, Kaiser Foundation Health Plan dominates mid-to-high premium ranges, and Aware Integrated, Inc. commands enrollment in the >$100 to <=$300 premium brackets.

Drug Overview

While zero-dollar drug deductibles were a hallmark of health insurance plans in the recent past, the trend has decidedly shifted. This year plans with drug deductibles exceeding $100 have become the more widespread offering. The number of plans in this high-deductible category surged from 2,317 in 2024 to 3,467 in 2025—a nearly 50% YoY increase. Alongside this expansion in plan offerings, enrollment in these plans also experienced substantial growth, rising from 10.23 million to 18.83 million, an 84.15% YoY increase. In contrast, the availability of $0 drug deductible plans declined sharply. The plan count dropped from 3,400 in 2024 to 2,184 in 2025, while enrollment plummeted from 16.91 million to just 9.62 million, with a 43.10% decline YoY.  

Mid-range deductible segments continued to decline in 2025. Plans in the >$50 to ≤$100 range dropped notably from 80 to just 46, accompanied by a decrease in enrollment to 190,004 members. The >$25 to ≤$50 tier remained largely insignificant, offering only eight plans and enrolling 30,289 beneficiaries. Notably, the >$0 to ≤$25 segment, which had maintained a minimal presence in prior years, disappeared entirely, registering neither plans nor enrollment.

At the state level, the shift is pronounced: Texas saw over $100 Deductible enrollment soar from 38% to 78%, while $0 deductible plans plunged from 61% to 20%. Similar trends played out in Florida, California, Pennsylvania, Georgia, and Arizona, pointing to a nationwide strategy among carriers to raise deductibles. Still, some smaller states, such as Rhode Island and Minnesota, maintain a moderate $0 deductible plan presence. UnitedHealth Group leads the higher deductible segment with over 7.6 million members, while Humana holds the largest share of $0 Deductible enrollment. CVS Health Corporation also has a strong presence in the higher deductible market, enrolling nearly 2.3 million members in the over $100 deductible category, representing 82.34% of its membership. Mid-range offerings remain niche, with modest gains only in states like Oregon, Indiana, Utah, and Connecticut.

MOOP Overview

Most plans now have a MOOP above $3,000, representing 88.8% of total plans in 2025. The Over $6000 MOOP category saw significant growth, adding 367 plans to reach 2,472, while mid-range MOOP categories declined. Plans lying in MOOP ranging from $3000 to <=$4500 dropped by 209, and >$4500 to <=$6000 MOOP plans fell by 123. Similarly, >$1500 to <=$3000 MOOP plans decreased by 91, indicating a shift away from moderate-cost options. Lower MOOP tiers followed different patterns, with >$0 to <=$500 MOOP plans increasing by 8, while >$500 to <=$1500 MOOP plans declined by 14.

Enrollment patterns reinforce this shift, as the Over $6000 MOOP category saw the most substantial increase in 2025, growing 21.29% YoY to 12.07 million enrollees, signaling a movement toward higher-cost-sharing plans. In contrast, the >$3000 to <=$4500 MOOP segment saw a decline in enrollment of 6.16% YoY to 7.07 million, and the >$4500 to <=$6000 MOOP category dropped 3.34% YoY, reflecting a reduction in mid-tier MOOP selections. Lower-cost MOOP brackets showed varying trends: $0 to <=$500 MOOP surged by 17.03% YoY, while >$500 to <=$3000 MOOP experienced minor declines. With affordability rising, the growing preference for higher MOOP plans highlights the increasing role of cost-sharing in the 2026 bid season.

At the state level, New York had the highest enrollment; MOOP is more than $6000 with 1.6 million enrollees, making up 95.94% of total enrollment. Among payors, UnitedHealth Group and Humana had around 50% of their members in this category, with 3.9 million and 2.5 million enrollees, respectively. Their next-largest enrollment was in the >$3000 to <=$4500 MOOP segment, reinforcing their dominance in higher cost-sharing plans.

Part B Giveback

From 2020 to 2025, the number of plans offering Part B Giveback has consistently increased, with the most significant YoY growth occurring in 2025, adding 861 plans to reach a total of 1,748. Enrollment in these plans has also surged, with the most dramatic increase in 2025, when enrollment jumped by 248% YoY to 8.68 million enrollments. Before this, enrollment growth was steady, with increases of 35% in 2022 (1.42 million), 41 % in 2023 (2.01 million), and 24 % in 2024 (2.50 million). The sharp rise in both the number of plans and enrollment in 2025 highlights the growing appeal of Part B Giveback benefits among insurers and beneficiaries.

Florida has the highest enrollment in plans offering Part B Giveback, with 1.2 million enrollees, comprising 14.95% of all Part B enrollees and Texas ranks second with 516,757 enrollees, representing 5.95%. Among payors, Humana leads in capturing more enrollees, with around 3.27 million enrollees (37.64% of total Part B Giveback enrollment), followed by UnitedHealth Group, which has 2.67 million enrollees (31.84%) with giveback offer.

Benefits

Supplemental Benefit Trends

  • Declining Availability, Yet High Impact: Despite fewer plans offering them, essential benefits like Emergency Care, Dental Preventive, and Physical Exams saw the highest enrollment gains (1M+ each).
  • SSBCI Gains: Food and General Supports for Living saw 5M+ and 3.5M+ enrollment gains respectively.

Supplemental benefits, which provide extra coverage beyond core Medicare services, saw a reduction in plan offerings across all benefits in 2025. Despite this, certain benefits drove significant enrollment gains, with Worldwide Emergency/Urgent Coverage, Outpatient Blood, Inpatient Hospital-Acute Services, and Physical Exams each adding 1.2 million enrollees. Similarly, Eye Exams and Dental Preventive Care attracted 1.1 million new members, while Eye Wear and Hearing Exams contributed an additional 1 million enrollees. These trends suggest that enrollees continue to prioritize essential and preventive healthcare services, even as plan availability declines. However, Dental Comprehensive benefits saw an enrollment drop of 260,888 members, while Over-the-Counter (OTC) benefits declined by 488,638 members. In addition to these, other supplemental benefits like Acupuncture, Chiropractic, and Transport also experienced notable enrollment losses.

Despite being included in fewer plans, Fitness Benefit remained the most widely available and continued to attract members, growing by 0.78 million enrollees. Alternative Therapies and Bathroom Safety Devices saw notable increases in enrollment, suggesting a rising demand for holistic and home-based care solutions. In contrast, benefits such as Remote Access Technology and Personal Emergency Response Systems (PERS) experienced sharp declines in enrollment, losing 6.28 million and 5.01 million enrollments, respectively, potentially due to shifting plan priorities or decreased demand. Meanwhile, Special Supplemental Benefits for the Chronically Ill (SSBCI) benefits showed mixed trends. Popular benefits like Food and Produce and General Supports for Living saw substantial growth in enrollment of 3.5 million and 3.2 million, respectively, highlighting a growing focus on social determinants of health. However, declining benefits such as Complementary Therapy and Services Supporting Self-Direction indicate that some specialized offerings are losing traction. These patterns underscore the need for insurers to strategically refine their benefits portfolios, ensuring that offerings align with evolving beneficiary needs while maintaining competitive differentiation in an increasingly saturated market.

Parent Organization Overview

As of February 2025, the Medicare enrollment landscape reflects a mix of strong growth and notable declines among key parent organizations. UnitedHealth Group, Inc. continues to dominate, adding 492,630 members since December 2024, reinforcing its market leadership. In contrast, Humana Inc. experienced the most significant decline, losing 432,319 enrollees, potentially due to strategic shifts, competitive pressures, or plan modifications. Similarly, CVS Health Corporation saw a reduction of 256,292 members, indicating possible repositioning within the Medicare space. On the growth side, Elevance Health, Inc. expanded by 173,380 members, maintaining a steady upward trajectory, while The Cigna Group gained 118,801 enrollees, highlighting increasing traction in its Medicare plans. Lifetime Healthcare, Inc. and Blue Cross Blue Shield of Michigan Mutual Ins. Co. recorded gains of 79,128 and 69,029 members, respectively, suggesting more substantial competitiveness and potential service area expansions. Kaiser Foundation Health Plan, Inc. saw a modest increase of 26,312 members, reflecting steady but slower growth. These shifts indicate evolving market dynamics, where some insurers are aggressively expanding while others face enrollment declines, likely influenced by plan affordability, benefit structures, and competitive pressures.

Conclusion

The 2025 MA market represented a year of strategic adjustments characterized by the dual forces of specialization and cost-effectiveness. Insurers directed increased attention toward high-need populations, resulting in remarkable growth in C-SNPs, while D-SNPs evolved and I-SNPs declined. Despite a decrease in plan options, traditional designs like Local HMOs and PPOs continued to anchor enrollments. At the same time, affordability-driven designs gained traction, with $0 and low-premium plans solidifying their market presence. Nevertheless, along with this premium strategy came an increase in cost-sharing, with MOOP costs surpassing $ 6,000 and drug deductibles exceeding $100, as insurers aimed to mitigate rising expenses. In contrast, Part B Giveback plans surged in popularity, providing an attractive affordability option for cost-sensitive enrollees. Even with a reduction in supplemental benefit options, members gravitated toward essential services such as physical Exams, Emergency coverage, vision, and Dental preventive care, while social and wellness-focused SSBCI benefits like Food and Produce and Temporary support also experienced significant enrollment increases.

As we approach the 2026 bidding season, insurers must thoughtfully balance the perception of affordability with actual cost-sharing requirements. Plans with $0 premiums will continue to be a competitive benchmark, but success will depend more on higher MOOP and deductible thresholds, along with distinct offerings that resonate with member needs, such as preventive care and financial assistance via the Part B Giveback program. With market saturation increasing, effective differentiation will rely on enhancing benefit portfolios, phasing out underperforming mid-tier products, and refining strategies for Giveback, SSBCI, and SNP growth. Ultimately, plans that deliver customized, value-focused experiences while effectively managing cost limitations will be best equipped to thrive in the evolving and highly competitive Medicare Advantage landscape.

Defining terms

** Net Enrollment is the difference between enrollment from February 2025 to December 2024.

Ranked in the Top 10%

Request A Personalized Demo
Let us show you how HealthWorksAI can optimize your Medicare Advantage product design efforts at every stage through actionable insights by leveraging public and private healthcare data.